(4aS,8aR,8bR,9aS,12S,12aS,13S,14aR,14bR)-12-(3-Furyl)-7,13-dihydroxy-6,6,8a,12a-tetramethyl-4,4a,8a,12,12a,13,14,14a-octahydro-3H-oxireno[d]pyrano[4',3':3,3a][2]benzofuro[5,4-f]isochromene-3,8,10(6H,9 aH)-trione

Basic Information

View in Editor

CAS Number

120722-04-5

Molecular Formula

C26H28O10

Molecular Weight

500.5 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ketones

Basic Chemical Raw Materials Organic Chemicals Esters

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Dyes and Pigments Organic Dyes

Fine Chemicals Surfactants Anionic Surfactants

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Physical State

Cryst.

Solubility

N/A

SMILES

View in Editor

CC1(C2=C(C(=O)C3(C(C24COC(=O)CC4O1)CC(C5(C36C(O6)C(=O)OC5C7=COC=C7)C)O)C)O)C

InChI

InChI=1S/C26H28O10/c1-22(2)17-16(29)18(30)23(3)12(25(17)10-33-15(28)8-14(25)35-22)7-13(27)24(4)19(11-5-6-32-9-11)34-21(31)20-26(23,24)36-20/h5-6,9,12-14,19-20,27,29H,7-8,10H2,1-4H3/t12-,13-,14-,19-,20+,23-,24-,25-,26-/m0/s1

InChIKey

GVZAWWJSPGIYFX-MLAPLXGTSA-N

LogP

1.9139999999999997

Topological Polar Surface Area

145.03 Å²

Hydrogen Bond Donor/Acceptor

2 / 10

Complexity

1140

Safety Information

View Safety Information

Storage Conditions

2-8℃

Synonyms & References

English

FS-10235
HY-N1026
(4AS,8aR,8bR,9aS,12S,12aS,13S,14aR,14bR)-12-(furan-3-yl)-7,13-dihydroxy-6,6,8a,12a-tetramethyl-4,4a,8a,12,12a,13,14,14a-octahydro-1H,3H-oxireno[2,3-d]pyrano[4',3':3,3a]isobenzofuro[5,4-f]isochromene-3,8,10(6H,9aH)-trione
CS-0016263
(-)-12
AKOS032962257
A-Hydroxyevodol
(-)-12alpha-Hydroxyevodol
120722-04-5
12alpha-Hydroxyevodol
(1R,2R,7S,13R,14R,16S,19S,20S,21S)-19-(furan-3-yl)-11,21-dihydroxy-9,9,13,20-tetramethyl-4,8,15,18-tetraoxahexacyclo[11.9.0.02,7.02,10.014,16.014,20]docos-10-ene-5,12,17-trione
11H,13H-Oxireno[d]pyrano[4',3':3,3a]isobenzofuro[5,4-f][2]benzopyran-4,6,13(2H,5aH)-trione,8-(3-furanyl)-4a,8,8a,9,10,10a,14,14a-octahydro-3,9-dihydroxy-2,2,4a,8a-tetramethyl-,[4aR-(4aa,4bR*,5ab,8b,8ab,9b,10ab,10bR*,14ab)]- (9CI)
11H,13H-Oxireno[d]pyrano[4',3':3,3a]isobenzofuro[5,4-f][2]benzopyran-4,6,13(2H,5aH)-trione,8-(...
11H,13H-Oxireno[d]pyrano[4',3':3,3a]isobenzofuro[5,4-f][2]benzopyran-4,6,13(2H,5aH)-trione,8-(3-furanyl)-4a,8,8a,9,10,10a,14,
11H,13H-Oxireno[d]pyrano[4',3':3,3a]isobenzofuro[5,4-f][2]benzopyran-4,6,13(2H,5aH)-trione,8-(3-furanyl)-4a,8,8a,9,10,10a,14,14a-octahydro-3,9-dihydroxy-2,2,4a,8a-tetramethyl-,[4aR-(4aa,4bR*,5ab,8b,8a
12ALPHA-HYDROXYEVODOL
12α-Hydroxyevodol
(-)-12a-Hydroxyevodol
Limonoicacid, 5,6-didehydro-6,12-dihydroxy-, 3,19:16,17-dilactone, (12a)-
[ "" ]

MDL Number

MFCD20260684

FAQ

What regulatory guidelines apply to (4aS,8aR,8bR,9aS,12S,12aS,13S,14aR,14bR)-12-(3-Furyl)-7,13-dihydroxy-6,6,8a,12a-tetramethyl-4,4a,8a,12,12a,13,14,14a-octahydro-3H-oxireno[d]pyrano[4',3':3,3a][2]benzofuro[5,4-f]isochromene-3,8,10(6H,9aH)-trione (CAS: 120722-04-5)?

This compound falls under the scope of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) and requires proper labeling, storage, and handling. In the European Union, it is regulated under the REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) framework. FDA and EPA may have additional requirements related to its use in pharmaceuticals and environmental regulations.

Are there alternatives to (4aS,8aR,8bR,9aS,12S,12aS,13S,14aR,14bR)-12-(3-Furyl)-7,13-dihydroxy-6,6,8a,12a-tetramethyl-4,4a,8a,12,12a,13,14,14a-octahydro-3H-oxireno[d]pyrano[4',3':3,3a][2]benzofuro[5,4-f]isochromene-3,8,10(6H,9aH)-trione (CAS: 120722-04-5) in synthesis?

There are several analogs and isomers that can be used as alternatives in synthesis, such as different furan-substituted isomers or related oxireno systems. Common alternative reagents might include various furan derivatives or other isocromene analogues.

What is the market or research trend for (4aS,8aR,8bR,9aS,12S,12aS,13S,14aR,14bR)-12-(3-Furyl)-7,13-dihydroxy-6,6,8a,12a-tetramethyl-4,4a,8a,12,12a,13,14,14a-octahydro-3H-oxireno[d]pyrano[4',3':3,3a][2]benzofuro[5,4-f]isochromene-3,8,10(6H,9aH)-trione (CAS: 120722-04-5)?

Research trends suggest increasing interest in this compound for its potential use in pharmaceuticals and materials science. Market trends indicate growing demand, particularly in the development of novel drugs and high-performance polymers. The compound's unique structure may drive further exploration in these fields.

How should waste containing (4aS,8aR,8bR,9aS,12S,12aS,13S,14aR,14bR)-12-(3-Furyl)-7,13-dihydroxy-6,6,8a,12a-tetramethyl-4,4a,8a,12,12a,13,14,14a-octahydro-3H-oxireno[d]pyrano[4',3':3,3a][2]benzofuro[5,4-f]isochromene-3,8,10(6H,9aH)-trione (CAS: 120722-04-5) be handled?

Waste containing this compound should be collected in appropriate containers and disposed of through incineration or professional waste disposal services. Environmental protection precautions should include ensuring no release into water bodies and adherence to local and national environmental regulations. Proper documentation and handling procedures are essential to comply with regulatory requirements.